Search

Clinical Articles / BY: Colin Mar, MD, FRCPC January/February 2018
... for invasive cancer and ductal carcinoma in situ (DCIS).[ 17 ] A retrospective study of provincial SMP data estimated rates of 5.4% for invasive cancer and 17.3% when DCIS was included, with the risk of overdiagnosis ... screens, and false-positives were reduced by an estimated 17.2%.[ 26 ] Two sites within the SMP are currently ...
Clinical Articles / BY: Amie Padilla-Thornton, MD, FRCPC January/February 2018
... for evaluation of screen-detected lesions in 2010,[ 17 ] and many breast diagnostic teams in the province have ...
Clinical Articles / BY: Katherine A. Blood, MD, PhD January/February 2018
... by many psychological, medical, and demographic factors.[ 17 ] In our study, 24% of patients opted for bilateral ...
Clinical Articles / BY: Rebecca Warburton, MD, FRCSC March 2018
... and can be costly and detrimental to cosmesis.[ 17,18 ] Reoperation occurs in 20% to 30% of BCS cases.[19] ...
Clinical Articles / BY: Connie G. Chiu, MD, FRCSC March 2018
... of cosmesis and its impact on self-image and recovery.[ 17 ] Of the numerous validated psychometric patient-reported ...
Clinical Articles / BY: Christine E. Simmons, MD, MSc, FRCPC March 2018
... of many clinical trials. To date, only the CREATE-X study[ 17 ] has demonstrated an improvement in DFS and OS in ...
Letters / BY: Lorne Verhulst, MD January/February 2018
... Committee. The Medicare Protection Act, Section 17, Subsection 1(b) states: “A person must not charge a ...
News January/February 2018
... and adoptive parents. Benefits are payable for up to 17 weeks at the rate of 50% of eligible income up to a ...
Clinical Articles / BY: Ken Seethram, MD, FRCSC, FACOG June 2018
... by the Human Genome Project, and new sequencing tools[ 17 ] are permitting screening for subchromosomal defects such ...
Clinical Articles / BY: Daniel Shearer, BSc June 2018
... comparing insulin lispro (Humalog) and regular insulin,[ 17 ] and a randomized controlled trial of insulin aspart ... examining lispro found no increased rate of preeclampsia,[ 17 ] while aspart was shown to result in a lower occurrence ... taking lispro had a lower HbA1c throughout gestation,[ 17 ] while women on aspart reported a nonsignificant ...